1982
DOI: 10.1172/jci110484
|View full text |Cite
|
Sign up to set email alerts
|

Studies of the function of natural killer-interferon system in patients with Sjögren syndrome.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
10
0
1

Year Published

1983
1983
2014
2014

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 41 publications
(11 citation statements)
references
References 27 publications
0
10
0
1
Order By: Relevance
“…The TPA-Con A CM was harvested after a 72-h incubation, and immediately added to the EC cultures for the lymphocyte-EC adhesion assay and endothelial DR expression assay. The interferon (IFN) activity in the TPA-Con A CM was determined by microcytopathic effect inhibition assay using encephalomyocarditis virus and FL cells (human amnion-derived cell line) as described elsewhere (21 Giemsa-stained.…”
Section: Methodsmentioning
confidence: 99%
“…The TPA-Con A CM was harvested after a 72-h incubation, and immediately added to the EC cultures for the lymphocyte-EC adhesion assay and endothelial DR expression assay. The interferon (IFN) activity in the TPA-Con A CM was determined by microcytopathic effect inhibition assay using encephalomyocarditis virus and FL cells (human amnion-derived cell line) as described elsewhere (21 Giemsa-stained.…”
Section: Methodsmentioning
confidence: 99%
“…HeLa-Ms cell monolayers was done as previously reported (Minato et al, 1982). Briefly, 1 ml of mononuclear cells at a concentration of 5 x lo6 cells/ml in RPMI 1640 medium containing 10% FCS were cultured for 18 h with 1 x lo5 HeLa-Ms cell monolayers in 24-well Linbro multiculture dishes (Flow Laboratories Inc., Rockville, Maryland, U.S.A.).…”
Section: Treatment Of Mononuclear Cells With Hela-ms Cells Treatmentmentioning
confidence: 99%
“…The origin and character of the factor(s) assumed to be present in sera of patients with HPV-induced anogenital lesions and responsible for specific inhibition of Sk-v cell lysis are as yet unknown. The "target-specificity" of the factor(s) excludes any relationship with a variety of non-specific factors inhibiting NCMC such as prostaglandins (Bankhurst, 1982), NK-specific antibodies (Goto et al, 1980), immune complexes (Silverman and Cathcart, 1980) or deficiency in production of NK-cell-augmenting factors (Minato et al, 1982). Serum factors inhibitory for NK-cell activity, apparently unrelated to immune complexes or anti-lymphocyte antibodies, have previously been detected in autoimmune disorders (Miyasaka et al, 1983) and in cancer patients (Holmes et al, 1986).…”
Section: Discussionmentioning
confidence: 99%